ロード中...

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

Because of its potent immunosuppressive yet stem cell–sparing activity, high-dose cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after myeloablative allogeneic bone marrow transplantation (alloBMT). We treated 117 patients (median age, 50 years; range, 21-66 year...

詳細記述

保存先:
書誌詳細
主要な著者: Luznik, Leo, Bolaños-Meade, Javier, Zahurak, Marianna, Chen, Allen R., Smith, B. Douglas, Brodsky, Robert, Huff, Carol Ann, Borrello, Ivan, Matsui, William, Powell, Jonathan D., Kasamon, Yvette, Goodman, Steven N., Hess, Allan, Levitsky, Hyam I., Ambinder, Richard F., Jones, Richard J., Fuchs, Ephraim J.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2010
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2858487/
https://ncbi.nlm.nih.gov/pubmed/20124511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-11-251595
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!